Relevance of frequent μ-opioid receptor polymorphisms for opioid activity in healthy volunteers (original) (raw)

• Wang JB, Johnson PS, Persico AM, Hawkins AL, Griffin CA, Uhl GR . Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 1994; 338: 217–222.
  Article CAS Google Scholar
• Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383: 819–823.
  Article CAS Google Scholar
• Skarke C, Darimont J, Schmidt H, Geisslinger G, Lötsch J . Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther 2003; 73: 107–121.
  Article CAS Google Scholar
• Lötsch J, Skarke C, Grösch S, Darimont J, Schmidt H, Geisslinger G . The polymorphism A118G of the human mu-opioid receptor gene decreases the clinical activity of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 2002; 12: 3–9.
  Article Google Scholar
• Romberg R, Olofsen E, Sarton E, den Hartigh J, Taschner PE, Dahan A . Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences. Anesthesiology 2004; 100: 120–133.
  Article CAS Google Scholar
• Romberg RR, Olofsen E, Bijl H, Taschner PE, Teppema LJ, Sarton EY et al. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology 2005; 102: 522–530.
  Article CAS Google Scholar
• Klepstad P, Rakvag TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC et al. The 118 A>G polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 2004; 48: 1232–1239.
  Article CAS Google Scholar
• Caraco Y, Maroz Y, Davidson E . Variability in alfentanil analgesia maybe attributed to polymorphism in the mu-opiod receptor gene. Clin Pharmacol Ther 2001; 69: p63.
  Google Scholar
• Lötsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C et al. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? Anesthesiology 2002; 97: 814–819.
  Article Google Scholar
• Hirota T, Ieiri I, Takane H, Sano H, Kawamoto K, Aono H et al. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. Drug Metab Dispos 2003; 31: 677–680.
  Article CAS Google Scholar
• Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 2000; 9: 2895–2908.
  Article CAS Google Scholar
• Skarke C, Jarrar M, Erb K, Schmidt H, Geisslinger G, Lötsch J . Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine. Clin Pharmacol Ther 2003; 74: 303–311.
  Article CAS Google Scholar
• Skarke C, Langer M, Jarrar M, Schmidt H, Geisslinger G, Lötsch J . Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humans. Anesthesiology 2004; 101: 1394–1399.
  Article CAS Google Scholar
• Lötsch J, Geisslinger G . Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 2005; 11: 82–89.
  Article Google Scholar
• LaForge KS, Yuferov V, Kreek MJ . Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol 2000; 410: 249–268.
  Article CAS Google Scholar
• Skarke C, Kirchhof A, Geisslinger G, Lötsch J . Comprehensive mu-opioid-receptor genotyping by pyrosequencing. Clin Chem 2004; 50: 640–644.
  Article CAS Google Scholar
• Niu T, Qin ZS, Xu X, Liu JS . Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 2002; 70: 157–169.
  Article CAS Google Scholar
• Bertilsson L . Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 1995; 29: 192–209.
  Article CAS Google Scholar
• Unadkat JD, Bartha F, Sheiner LB . Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin Pharmacol Ther 1986; 40: 86–93.
  Article CAS Google Scholar
• Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J . Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25: 358–371.
  Article CAS Google Scholar
• Hull CJ, Van Beem HB, McLeod K, Sibbald A, Watson MJ . A pharmacodynamic model for pancuronium. Br J Anaesth 1978; 50: 1113–1123.
  Article CAS Google Scholar
• Holford NH, Sheiner LB . Understanding the dose–effect relationship: clinical application of pharmacokinetic–pharmacodynamic models. Clin Pharmacokinet 1981; 6: 429–453.
  Article CAS Google Scholar
• Boeckmann AJ, Sheiner LB, Beal SL . NONMEM User's Guide. University of California San Francisco: San Francisco, 1994.
  Google Scholar
• Penson RT, Joel SP, Clark S, Gloyne A, Slevin ML . Limited phase I study of morphine-3-glucuronide. J Pharm Sci 2001; 90: 1810–1816.
  Article CAS Google Scholar
• Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML . Randomized placebo controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 2000; 68: 667–676.
  Article CAS Google Scholar
• Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S et al. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 2002; 26: 106–114.
  Article CAS Google Scholar
• Hernandez-Avila CA, Wand G, Luo X, Gelernter J, Kranzler HR . Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet 2003; 118B: 60–65.
  Article Google Scholar
• Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608–9613.
  Article CAS Google Scholar
• Beyer A, Koch T, Schroder H, Schulz S, Höllt V . Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 2004; 89: 553–560.
  Article CAS Google Scholar
• Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL . A single-nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 2001; 276: 3130–3137.
  Article CAS Google Scholar
• Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W . Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280: 32618–32624 (Epub 2005 July 26).
  Article CAS Google Scholar
• LaForge KS, Shick V, Spangler R, Proudnikov D, Yuferov V, Lysov Y et al. Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction. Am J Med Genet 2000; 96: 604–615.
  Article CAS Google Scholar
• Berrettini WH, Hoehe MR, Ferraro TN, Demaria PA, Gottheil E . Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict Biol 1997; 2: 303–308.
  Article CAS Google Scholar
• Urraca N, Camarena B, Gomez-Caudillo L, Esmer MC, Nicolini H . micro opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. Am J Med Genet 2004; 127B: 94–96.
  Article CAS Google Scholar
• Gelernter J, Kranzler H, Cubells J . Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatr 1999; 4: 476–483.
  Article CAS Google Scholar
• Ette EI, Williams PJ . Population pharmacokinetics II: estimation methods. Ann Pharmacother 2004; 38: 1907–1915.
  Article CAS Google Scholar
• Luo X, Kranzler HR, Zhao H, Gelernter J . Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet 2003; 120B: 97–108.
  Article Google Scholar
• Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatr 1997; 2: 490–494.
  Article CAS Google Scholar